Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more

New England Journal of Medicine

Volumn 354, Issue 18, 2006, Pages 1889-1900

  Newman, Thomas B ^a,b   Liljestrand, Petra ^a,b   Jeremy, Rita J ^a   Ferriero, Donna M ^a   Wu, Yvonne W ^a   Hudes, Esther S ^a   Escobar, Gabriel J ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ARTICLE; BEHAVIOR DISORDER; BILIRUBIN BLOOD LEVEL; COGNITION; CONTROLLED STUDY; COOMBS TEST; ELECTRONIC MEDICAL RECORD; EXCHANGE BLOOD TRANSFUSION; FOLLOW UP; HUMAN; HYPERBILIRUBINEMIA; INFANT; INTERVIEW; KERNICTERUS; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEWBORN; NEWBORN ASSESSMENT; PHOTOTHERAPY; PRIORITY JOURNAL; QUESTIONNAIRE; BLOOD; CASE CONTROL STUDY; CHILD DEVELOPMENT; COHORT ANALYSIS; FEMALE; GESTATIONAL AGE; INTELLIGENCE; MALE; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NEWBORN JAUNDICE; OUTCOME ASSESSMENT; PSYCHOLOGICAL ASPECT; SINGLE BLIND PROCEDURE; SOCIOECONOMICS; STATISTICAL MODEL;

BILIRUBIN; CASE-CONTROL STUDIES; CHILD DEVELOPMENT; COHORT STUDIES; COMBINED MODALITY THERAPY; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; GESTATIONAL AGE; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; INTELLIGENCE; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT (HEALTH CARE); PHOTOTHERAPY; QUESTIONNAIRES; SINGLE-BLIND METHOD; SOCIOECONOMIC FACTORS;

EID: 33646376962     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa054244     Document Type: Article

References (35)

1. Ip S, Chung M, Kulig J, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004;114:e130-e153.
2. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316. [Erratum, Pediatrics 2004;114:1138.]
3. Madan A, McMahon J, Stevenson D. Neonatal hyperbilirubinemia. In: Taeusch HW, Ballard RA, Gleason CA, eds. Avery's diseases of the newborn. 8th ed. Philadelphia: Elsevier Saunders, 2004:1247.
4. Newman TB, Maisels MJ. Does hyperbilirubinemia damage the brain of healthy full-term infants? Clin Perinatol 1990;17:331-58.
5. Watchko JF. Vigintiphobia revisited. Pediatrics 2005;115:1747-53.
6. Scheidt PC, Graubard BI, Nelson KB, et al. Intelligence at six years in relation to neonatal bilirubin levels: follow-up of the National Institute of Child Health and Human Development Clinical Trial of Phototherapy. Pediatrics 1991;87:797-805.
7. Nilsen ST, Finne PH, Bergsjo P, Stamnes O. Males with neonatal hyperbilirubinemia examined at 18 years of age. Acta Paediatr Scand 1984;73:176-80.
8. Seidman DS, Paz I, Stevenson DK, Laor A, Danon YL, Gale R. Neonatal hyperbilirubinemia and physical and cognitive performance at 17 years of age. Pediatrics 1991;88:828-33.
9. Soorani-Lunsing I, Woltil HA, Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain? Pediatr Res 2001;50:701-5.
10. Grimmer I, Berger-Jones K, Buhrer C, Brandl U, Obladen M. Late neurological sequelae of non-hemolytic hyperbilirubinemia of healthy term neonates. Acta Paediatr 1999;88:661-3.
11. Ozmert E, Erdem G, Topçu M, et al. Long-term follow-up of indirect hyperbilirubinemia in full-term Turkish infants. Acta Paediatr 1996;85:1440-4.
12. Yilmaz Y, Karadeniz L, Yildiz F, Degirmenci SY, Say A. Neurological prognosis in term newborns with neonatal indirect hyperbilirubinemia. Indian Pediatr 2001;38:165-8.
13. Holmes GE, Miller JB, Smith EE. Neonatal bilirubinemia in production of longterm neurological deficits. Am J Dis Child 1968;116:37-43.
14. Newman TB, Escobar GJ, Gonzales VM, Armstrong MA, Gardner MN, Folck BF. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics 1999;104:1198-203.
15. Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 2000;154:1140-7.
16. Atkinson LR, Escobar Gj, Takayama Ji, Newman TB. Phototherapy use in jaundiced newborns in a large managed care organization: do physicians adhere to the guideline? Pediatrics 2003;111:e555-e561.
17. Escobar GJ, Gonzales VM, Armstrong MA, Folck BF, Xiong B, Newman TB. Rehospitalization for neonatal dehydration: a nested case-control study. Arch Pediatr Adolesc Med 2002;156:155-61.
18. Civic D, Holt VL. Maternal depressive symptoms and child behavior problems in a nationally representative normal birthweight sample. Matern Child Health J 2000;4:215-21.
19. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. J Appl Psychol Meas 1977;1:385-401.
20. Wechsler D. The Wechsler Preschool and Primary Scale of Intelligence - Revised. San Antonio, Tex.: Psychological Corporation, 1989.
21. Beery K. The Beery-Buktenica Developmental Test of Visual-Motor Integration. 4th ed. rev. Parsippany, N.J.: Modern Curriculum Press, 1997.
22. Gwynne K, Blick B. Motor performance checklist for 5-year-olds: a tool for identifying children at risk of developmental co-ordination disorder. J Paediatr Child Health 2004;40:369-73.
23. Glascoe FP. Collaborating with parents: using parents' evaluations of developmental status to detect and address developmental and behavioral problems. Nash ville: Ellsworth & Vandemeer Press, 1998.
24. Achenbach TM. The Child Behavior Checklist/4-18 and 1991 Profile Manual. Burlington, Vt.: University Associates in Psychiatry, 1991.
25. Newman TB, Liljestrand P, Escobar GJ. Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization. Pediatrics 2003;111:1303-11.
26. Wu Y, Liljestrand P, Ferriero D, et al. Prevalence of motor abnormalities among healthy 5-year-old children. Pediatr Neurol 2005;3:141-6.
27. Newman TB, Klebanoff MA. Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. Pediatrics 1993;92:651-7.
28. Newman TB, Klebanoff MA. Idem. 33 272 Infants, 7-year follow-up: total serum bilirubin, transfusions reexamined. Pediatrics 2002;110:1032.
29. Day R, Haines MS. Intelligence quotients of children recovered from erythroblastosis fetalis since the introduction of exchange transfusion. Pediatrics 1954;13:333-8.
30. Hyman CB, Keaster J, Hanson V, et al. CNS abnormalities after neonatal hemolytic disease or hyperbilirubinemia: a prospective study of 405 patients. Am J Dis Child 1969;117:395-405.
31. Johnston WH, Angara V, Baumal R, et al. Erythroblastosis fetalis and hyperbilirubinemia: a five-year follow-up with neurological, psychological, and audiological evaluation. Pediatrics 1967;39:88-92.
32. Ashwal S, Russman BS, Blasco PA, et al. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2004;62:851-63.
33. Wu Y, Escobar GJ, Grether JK, Croen LA, Greene JD, Newman TB. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA 2003;290:2677-84.
34. Winter S, Autry A, Boyle C, Yeargin-Allsopp M. Trends in the prevalence of cerebral palsy in a population-based study. Pediatrics 2002;110:1220-5.
35. Colver AF, Gibson M, Hey EN, Jarvis SN, Mackie PC, Richmond S. Increasing rates of cerebral palsy across the severity spectrum in north-east England 1964-1993: the North of England Collaborative Cerebral Palsy Survey. Arch Dis Child Fetal Neonatal Ed 2000;83:F7-F12.